These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35940315)

  • 1. Donor and Recipient Hepatitis C Status Does Not Affect Rejection in Thoracic Transplantation.
    Ganapathi AM; Whitson BA; Heh V; Keller BC; Smith SA; Mokadam NA; Henn MC
    Ann Thorac Surg; 2023 Jan; 115(1):221-230. PubMed ID: 35940315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor and recipient hepatitis C status in lung transplantation.
    Englum BR; Ganapathi AM; Speicher PJ; Gulack BC; Snyder LD; Davis RD; Hartwig MG
    J Heart Lung Transplant; 2016 Feb; 35(2):228-35. PubMed ID: 26615769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes.
    Kim ST; Xia Y; Ho JK; Lowery E; McCarthy DP; Ardehali A
    J Heart Lung Transplant; 2024 Feb; 43(2):337-345. PubMed ID: 37866469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
    Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E
    JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors.
    Diaz-Castrillon CE; Huckaby LV; Witer L; Pope NH; Katz MR; Baliga PK; Kilic A
    Clin Transplant; 2022 Apr; 36(4):e14581. PubMed ID: 34974630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE; Marino G; Kuo PC; Plotkin JS; Rustgi VK; Lu AD; Edwards E; Taranto S; Johnson LB
    Liver Transpl; 2001 Sep; 7(9):762-8. PubMed ID: 11552208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis C infection on outcomes after heart transplantation.
    Fong TL; Hou L; Hutchinson IV; Cicciarelli JC; Cho YW
    Transplantation; 2009 Nov; 88(9):1137-41. PubMed ID: 19898211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
    Bae S; Durand CM; Garonzik-Wang JM; Chow EKH; Kucirka LM; McAdams-DeMarco MA; Massie AB; Al Ammary F; Coresh J; Segev DL
    Transplantation; 2020 Jun; 104(6):1294-1303. PubMed ID: 32433232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in use and three-year outcomes of hepatitis C virus-viremic donor lung transplants for hepatitis C virus-seronegative recipients.
    Ruck JM; Zeiser LB; Zhou AL; Chidi AP; Winchester SL; Durand CM; Ha JS; Shah PD; Massie AB; Segev DL; Merlo CA; Bush EL
    J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1587-1595.e2. PubMed ID: 36207160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Donor and Recipient Age: Older Lung Transplant Recipients Do Not Require Younger Lungs.
    Hall DJ; Jeng EI; Gregg JA; Pelaez A; Emtiazjoo AM; Chandrashekaran S; Pipkin M; Beaver TM; Machuca TN
    Ann Thorac Surg; 2019 Mar; 107(3):868-876. PubMed ID: 30444994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.
    Layden JE; Cotler SJ; Grim SA; Fischer MJ; Lucey MR; Clark NM
    Transplantation; 2012 Feb; 93(4):444-9. PubMed ID: 22277982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of liver grafts procured from hepatitis C-positive donors.
    Velidedeoglu E; Desai NM; Campos L; Olthoff KM; Shaked A; Nunes F; Zeldin G; Stewart C; Blumberg E; Abrams J; Markmann JF
    Transplantation; 2002 Feb; 73(4):582-7. PubMed ID: 11889435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Outcomes of Multivisceral Transplant Using Hepatitis C-Positive Donors.
    McMaster WG; Rahaman ZM; Shipe ME; Quintana EN; Sandhaus EM; Smith SS; Crockett JE; Forbes RC; Schlendorf KH; Shah AS
    Ann Thorac Surg; 2021 Aug; 112(2):511-518. PubMed ID: 33121968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.